Your browser doesn't support javascript.
loading
Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types.
Martin-Romano, Patricia; Castanon, Eduardo; Ammari, Samy; Champiat, Stéphane; Hollebecque, Antoine; Postel-Vinay, Sophie; Baldini, Capucine; Varga, Andrea; Michot, Jean Marie; Vuagnat, Perrine; Marabelle, Aurélien; Soria, Jean-Charles; Ferté, Charles; Massard, Christophe.
Afiliação
  • Martin-Romano P; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Castanon E; Oncology Department, Clínica Universidad de Navarra, Madrid, Spain.
  • Ammari S; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Champiat S; Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Hollebecque A; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Postel-Vinay S; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Baldini C; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Varga A; INSERM, VILLEJUIF, France.
  • Michot JM; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Vuagnat P; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Marabelle A; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Soria JC; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Ferté C; Drug Development Department (DITEP), Gustave Roussy, Saclay University of Paris, Villejuif, France.
  • Massard C; INSERM, VILLEJUIF, France.
Cancer Med ; 9(8): 2643-2652, 2020 04.
Article em En | MEDLINE | ID: mdl-32074405
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article